Browsing by Subject "disease management"
Now showing 1 - 3 of 3
Results Per Page
Sort Options
Item 2022 Midwest broccoli trial results(2023-01-26) Hoidal, Natalie; Rohwer, Charlie; Enjalbert, NicoDisease pressure and climate change pose significant challenges to growing broccoli in the Midwest. Since around 2018, the pathogens black rot (Xanthamonas campestris pv. campestris) and Alternaria (Alternaria spp.) have become common on farms and in gardens, with some growers reporting 80-100% yield losses. Especially for organic growers, varietal tolerance can be a powerful tool for disease management. We conducted replicated broccoli trials at the Southern Research and Outreach Center (SROC) in Waseca, Minnesota, where we inoculated plots with black rot (Xanthamonas campestris pv. campestris). We also partnered with 88 farmers and gardeners to conduct mini trials at their farms and gardens. Our goal was to screen for varieties of broccoli with tolerance to the pathogens black rot and Alternaria, as well as environmental challenges like warm fall nights and high heat in the summer. This report outlines the results of the 2022 trial with overall takeaways and variety recommendations from both 2021 and 2022.Item The Healthcare Future for the iGeneration: Integrating the Patient and the Healthcare System(University of Minnesota, College of Pharmacy, 2013) Wood, Kristina D.; Greene, Elisa M.; Franks, Rachel B.; Poole, Traci M.; Ficzere, Cathy H.; Johnston, Philip E.Objective: To propose a vision to integrate patients, their health-related data, and their wellness plans into the healthcare system using smartphone and tablet computer technology. Setting: Ambulatory care and community practice Practice Innovation: Utilization of smartphone and tablet computer technology to assess health care conditions, educate and involve patients, and facilitate seamless communication between the patient, electronic health record, pharmacy system, third-party payers, point-of-care testing, and all health-care providers. Main Outcome Measures: By providing integrated and customized information at the point of use, medication adherence and access to care will be increased and patients will engage in healthy behaviors more often resulting in an improved level of care for patients. Results: In the future, the authors believe if the vision is achieved, the health care system and patients will see improved health outcomes and more efficient utilization of the healthcare system. Conclusions: Our proposed use of technology provides an opportunity to empower patients to positively improve their own health which could be a vital advancement in health care, especially in the areas of medication adherence, improving access to care, and health behavior support. As pharmacists, we may also embrace technology opportunities to expand our roles as health care professionals as we continue to partner with patients and the health care team to improve outcomes.Item Retrospective Analysis of Medication Adherence and Cost Following Medication Therapy Management(University of Minnesota, College of Pharmacy, 2010) Branham, Ashley; Moose, Joseph; Ferreri, StefanieObjective: To determine if pharmacist-provided medication therapy management (MTM) improves medication adherence in Medicare patients. A secondary objective is to compare the total monthly cost of a patient’s prescription medication regimen 6 months before and 6 months following a comprehensive medication review (CMR). Design: Retrospective analysis of medication adherence, pre-post comparison. Setting: Three independent pharmacies in North Carolina. Patients: 97 Medicare Part D beneficiaries with one or more chronic disease states who participated in a comprehensive medication review (CMR). Intervention: MTM services provided by community pharmacists. Main outcome measure: Change in adherence as measured by the proportion of days covered (PDC) and change in medication costs for patients and third party payers. Results: Patients were adherent to chronic disease-state medications before and after MTM (PDC≥ 0.8). Overall, change in mean adherence before and after MTM did not change significantly (0.87 and 0.88, respectively; p = 0.43). However, patients taking medications for cholesterol management, GERD, thyroid and BPH demonstrated improved adherence following a CMR. No change in adherence was noted for patients using antihypertensives and antidiabetic agents. Average total chronic disease-state medication costs for participants were reduced from $210.74 to $193.63 (p=0.08) following the comprehensive medication review. Total costs for patient and third party payers decreased from patients prescribed antilipemics, antihypertensives, GERD and thyroid disorders following a CMR. Conclusions: Pharmacist-provided MTM services were effective at improving medication adherence for some patients managed with chronic medications. Pharmacist-provided MTM services also were effective in decreasing total medication costs.